Where does Aprecia Pharmaceuticals LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aprecia Pharmaceuticals LLC ranks #13,861 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aprecia Pharmaceuticals LLC hold?

Aprecia Pharmaceuticals LLC holds 21 US utility patents granted between 2016 and 2025, spanning 11 technology areas.

What is Aprecia Pharmaceuticals LLC's Innovation Score?

Aprecia Pharmaceuticals LLC has an Innovation Score of 42.9 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Aprecia Pharmaceuticals LLC's patent grant rate increasing or decreasing?

Aprecia Pharmaceuticals LLC's recent grant velocity is -54% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Aprecia Pharmaceuticals LLC's patents?

Aprecia Pharmaceuticals LLC's patents average 23.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aprecia Pharmaceuticals LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aprecia Pharmaceuticals LLC

Q: What technology areas does Aprecia Pharmaceuticals LLC focus on?

Aprecia Pharmaceuticals LLC's top technology area is B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering) with 14 patents, ranking #130 of 1,250 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 21 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aprecia ranks #13,861 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 11 technology areas.

#13,861
of 49,997 US assignees by volume: Top 29%
by Innovation Score (42.9/100): 23.1
avg claims per patent: -54%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13861 · US Corporation #13,861 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,861/49,997
PHOTO-FINISH American AIR Filter
CPC-FOCUS B33Y · 11 areas
INNOV-PAR 42.9/100
CLAIMS-DENSE 23.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -54% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: American AIR Filter Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aprecia’s 42.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (25%) Velocity 6.7 pts (16%) Breadth 11.7 pts (27%) Claim depth 13.9 pts (32%)

Qualcomm Incorporated · highest

85
Aprecia Pharmaceutic… · this assignee

43
3D Lighting… · lowest

7

What this shows Aprecia's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aprecia?

Each dot is one of Aprecia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aprecia’s own 23.1 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Aprecia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aprecia's grants concentrate

Aprecia Pharmaceuticals LLC is a focused PatentsView assignee: 11 CPC subclasses with 66.7% of grants classified under B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2023. By volume, Aprecia sits between American AIR Filter Company, Inc. and Asterias Biotherapeutics, Inc..

Aprecia's three-year grant acceleration

Aprecia Pharmaceuticals LLC shows 4 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

American AIR Filt…

21
Amperity

21
Aosense

21
Applied Medical T…

21
ARB Labs

21
Artika FOR Living

21
Ascentage Pharma…

21
Asterias Biothera…

21
Aprecia Pharmaceu… ◀

21

What this shows Aprecia holds 21 patents at rank #13,844, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aprecia

By rank, the assignees closest to #13,844 in granted patent volume.

Leaders in B33Y (Additive Manufacturing)

Other assignees with the most granted patents in Aprecia's primary technology class.

Aprecia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Aprecia Pharmaceuticals LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	5	23.8%
2017	3	14.3%
2018	3	14.3%
2019	2	9.5%
2021	2	9.5%
2022	3	14.3%
2023	1	4.8%
2025partial year	2	9.5%

Which technologies does Aprecia Pharmaceuticals LLC patent most?

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 14

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 8

Y10T - Technical Subjects Covered BY Former US Classification 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 5

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

B30B - Presses IN General 2

B28B - Shaping Clay OR Other Ceramic COMPOSITIONS; Shaping SLAG; Shaping Mixtures Containing Cementitious Material, e.g. Plaster 2

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aprecia Pharmaceuticals LLC's patent record in context - here's where to go next.

Aprecia Pharmaceuticals LLC's lead technology class is B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ), 66.7% of its portfolio - see every assignee active in that class. Explore B33Y
Ranked #13,861 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aprecia Pharmaceuticals LLC against American AIR Filter Company, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.